Remix Therapeutics, a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, announced the appointment of...
Frontage Holdings Corporation ("Frontage") is pleased to announce that Mr. Henry Gao has been appointed as its Chief Financial Officer ("CFO"), effective February 1, 2024. As CFO,...
North Memorial Health's Board of Trustees has named Trevor Sawallish as its Chief Executive Officer, effective February 9, 2024. Sawallish has more than 20 years of experience...
Netlogistik, the leader in powerful services that guide companies toward the digital transformation of the supply chain, announces that Antonio (Toño) García becomes the...
EnteroBiotix Limited (“EBX”), a clinical stage biopharmaceutical company with the premier platform for full-spectrum microbiome therapeutics, announced the appointments of Dr James Barnes as...
